|Stock Description||This stock is from Pharmaceuticals sector.|
|Investment Rationale||Efficient drug maker
The company manufactures pharmaceutical formulations in the form of tablets, ointments and capsules, liquid orals and oral powders.
Company holds a dominant position in Latin America.
Debt-free business model with benchmark receivables.
Company is entering into Regulated markets of US, EU, Brazil, Mexico, Australia, with a state of the art manufacturing facility for Injectables, already approved by EU-GMP, ANVISA and US FDA.
They are undergoing expansion
With Expansion plans in place investors can foresee the Sales growth and the earnings growth in near future and hence stock price appreciation. Market rewards performing stocks
|Performance||The company has grown about 10 times+ in last 10years in Sales|
|% Return Prospects||GOOD if Invested for 3-5years time frame.|
|Market Cap size cataegory||Mid Cap|
|Personal Holding Information||No|
|FII/DII/Mutual Fund Holdings||Yes|
It is expected that Investor BUYs the stock advised as soon as possible.If delayed it may get expensive and returns would be reduced.Once the payment is done ,the stocks Equity Research Report [PDF format ] will be delievered to your Email ID.The Equity Research Report email sometimes land up in other tabs such as Promotion,Forum or spam etc apart from Inbox.
|*Past performances doesnt gaurantee returns in the future.Returns is expected if the company itself performs well and market sentiments are good and not too negative.As of the current situation this is a Valuable stock to BUY. Investors Advised to BUY this Stock in good Investing spirit.|
|Investors can reap good returns from the ADVISED Stocks if they stay invested for 3-5 Years[or more] Time frame.|